tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Okyo Pharma reports Phase 2 clinical trial results for urcosimod
PremiumThe FlyOkyo Pharma reports Phase 2 clinical trial results for urcosimod
24d ago
OKYO Pharma CEO to Present Urcosimod Development at Bio International Convention
Premium
Company Announcements
OKYO Pharma CEO to Present Urcosimod Development at Bio International Convention
2M ago
OKYO Pharma CEO to Present at Boston Drug Discovery Summit
Premium
Company Announcements
OKYO Pharma CEO to Present at Boston Drug Discovery Summit
3M ago
Okyo Pharma announces plans to accelerate development of urcosimod
PremiumThe FlyOkyo Pharma announces plans to accelerate development of urcosimod
3M ago
OKYO Pharma Achieves Key Stability Milestone for Urcosimod
Premium
Company Announcements
OKYO Pharma Achieves Key Stability Milestone for Urcosimod
4M ago
Okyo Pharma announces data on long-term stability of urcosimod
Premium
The Fly
Okyo Pharma announces data on long-term stability of urcosimod
4M ago
Okyo Pharma announces OK-101 officially assigned USAN, urcosimod
PremiumThe FlyOkyo Pharma announces OK-101 officially assigned USAN, urcosimod
6M ago
Yi Chen’s Buy Recommendation on OKYO Pharma: Promising Potential of OK-101 for Neuropathic Corneal Pain Amid Financial and Regulatory Challenges
Premium
Ratings
Yi Chen’s Buy Recommendation on OKYO Pharma: Promising Potential of OK-101 for Neuropathic Corneal Pain Amid Financial and Regulatory Challenges
6M ago
OKYO Pharma Executives Increase Shareholdings, Affirming Market Confidence
Premium
Company Announcements
OKYO Pharma Executives Increase Shareholdings, Affirming Market Confidence
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100